Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-2788
Title: Economic evaluation of oral versus parenteral iron therapy for iron deficiency without anemia
Authors : Mattli, Renato
Riguzzi, Marco
Glinz, Dominik
Raatz, Heike
Bucher, Heinz C.
Wieser, Simon
Extent : 22
Publisher / Ed. Institution : Bundesamt für Gesundheit
Publisher / Ed. Institution: Bern
Issue Date: Jun-2018
License (according to publishing contract) : Licence according to publishing contract
Language : English
Subject (DDC) : 362: Health and social services
Abstract: The Swiss Federal Office of Public Health (SFOPH) commissioned a Health Technology Assessment (HTA) regarding iron therapy in symptomatic patients with iron deficiency without anemia (iron deficiency no anemia, IDNA) to the Basel Institute for Clinical Epidemiology and Biostatistics (CEB) and the Winterthur Institute of Health Economics (WIG). The scope, which describes the background of the HTA and elucidates the general approach, has been published on the SFOPH homepage. This HTA followed a step-wise approach. The aim of the first step was to assess the clinical effectiveness of iron therapy in symptomatic patients with IDNA, and to identify symptomatic populations that benefit from the therapy. In this first step, the clinical effectiveness of iron therapy was assessed in comparison to any other non-iron treatment or placebo, irrespective of the route of iron administration. This step was conducted by CEB, and the results are summarized in chapter 2 of this document. In the second step, which will be conducted by WIG, the economic evaluation shall compare parenteral versus oral iron therapy for those populations, for which a significant treatment effect of iron therapy (parenteral or oral) versus control could be identified during the first step. Based on the effectiveness results, the scope of the economic evaluation is outlined in chapter 4. Section 4.1 defines the objective of the economic evaluation. Section 4.2 defines the population, the intervention, the comparator, and the outcome (PICO) which will be evaluated. A screening of health economic literature and publicly available HTAs for economic studies comparing parenteral with oral iron therapy is presented in section 4.3, and section 4.4 concludes with the outline of the research methodology of the economic evaluation.
Departement: School of Management and Law
Organisational Unit: Winterthur Institute of Health Economics (WIG)
Publication type: Working paper – expertise – study
DOI : 10.21256/zhaw-2788
URI: https://digitalcollection.zhaw.ch/handle/11475/15996
Appears in Collections:Publikationen School of Management and Law



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.